GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS)

Symbol: ABOS on Nasdaq
Investment type: Equity / Common stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$865,686	410,206	+11,428	+2.9%	$2.11	Q4 2025
30 Sep 2025	0%	0%	$682,039	398,778	+2,152	+0.54%	$1.71	Q3 2025
30 Jun 2025	0%	-0%	$460,166	396,626	-465,273	-54%	$1.16	Q2 2025
31 Mar 2025	0%	-0%	$948,182	861,899	-8,656		$1.10	Q1 2025
31 Dec 2024	0%	+0%	$1,497,500	870,555	+6,027	+0.7%	$1.72	Q4 2024
30 Sep 2024	0%	+0%	$2,144,198	864,528	+52,395	+6.5%	$2.48	Q3 2024
30 Jun 2024	0%	+0%	$1,965,534	812,133	+526,994	+185%	$2.42	Q2 2024
31 Mar 2024	0%	+0%	$1,155,091	285,139	+20,536	+7.8%	$4.05	Q1 2024
31 Dec 2023	0%	0%	$1,016,317	264,603	0		$3.84	Q4 2023
30 Sep 2023	0%	+0%	$1,098,390	264,603	+97,783	+59%	$4.15	Q3 2023
30 Jun 2023	0%	0%	$802,404	166,820	0		$4.81	Q2 2023
31 Mar 2023	0%	0%	$677,289	166,820	0		$4.06	Q1 2023
31 Dec 2022	0%	+0%	$900,000	166,820	+9,175	+5.8%	$5.40	Q4 2022
30 Sep 2022	0%	+0%	$1,581,000	157,645	+48,796	+45%	$10.03	Q3 2022
30 Jun 2022	0%	-0%	$511,000	108,849	-233,797	-68%	$4.69	Q2 2022
31 Mar 2022	0%	+0%	$1,339,000	342,646	+170,767	+99%	$3.91	Q1 2022
31 Dec 2021	0%	+0%	$1,161,000	171,879	+64,073	+59%	$6.75	Q4 2021
30 Sep 2021	0%	+0%	$1,601,000	107,806	+107,806	NEW	$14.85	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.